[Promotion of HBeAg seroconversion/loss in patients with chronic hepatitis B following the switch from nucleoside drugs to telbivudine and adefovir].

Cui, Sunan; Wang, Mingming; Gong, Yanxue

Cui, Sunan; Wang, Mingming; Gong, Yanxue.

Zhonghua Gan Zang Bing Za Zhi ; 22(10): 776-8, 2014 Oct.

Article in Zh | MEDLINE | ID: mdl-25558499

Subject(s)

Adenine/analogs & derivatives; Hepatitis B e Antigens/blood; Hepatitis B, Chronic/drug therapy; Nucleic Acid Synthesis Inhibitors/therapeutic use; Nucleosides/antagonists & inhibitors; Nucleosides/biosynthesis; Organophosphonates/therapeutic use; Thymidine/analogs & derivatives; Adenine/therapeutic use; Drug Combinations; Humans; Telbivudine; Thymidine/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thymidine / Adenine / Nucleic Acid Synthesis Inhibitors / Hepatitis B, Chronic / Organophosphonates / Hepatitis B e Antigens / Nucleosides Limits: Humans Language: Zh Journal: Zhonghua Gan Zang Bing Za Zhi Journal subject: GASTROENTEROLOGIA Year: 2014 Type: Article

Search on Google

XML

PubMed Links